PDGFRA and gastrointestinal stromal tumor: The roles of this RTK in cancer have been extensively studied in the context of gastrointestinal stromal tumors (GIST) where activating point mutations on PDGFRA are found in 5–7% of GIST cases [97] (reviewed in[98]).